Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Recipharm Site Approved for Japan Supply | Contract Pharma
Breaking News

Recipharm Site Approved for Japan Supply

Fontaine solid dose facility secures approval

Recipharm’s solid dose facility in Fontaine, France has been approved for supply of manufactured products to the Japanese pharmaceuticals market following a recent inspection by the Japanese drug agency, PMDA. The Fontaine site, acquired in 2009 from Solvay Pharma (now Abbott), is also approved to supply to the U.S. and has a distribution center for delivery to pharmacy level in France.
 
Stéphane Guisado, general manager of the Fontaine site, said, “We are very pleased to have secured this approval. Supplying products to Japan involves carrying out a substantial number of additional activities and meeting stringent requirements for enhanced quality control and we have met these challenges head on. We were also able to draw upon experience from other Recipharm sites, which are already supplying this key market. As a result of this approval, we are now in a good position to further support other customers with their plans to penetrate and expand sales in specific pharmaceutical markets within Japan.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters